Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
Wildemann
B
B
Schülin
C
C
Storch-Hagenlocher
B
B
Hacke
W
W
Dithmar
S
S
Kirchhof
K
K
Jansen
O
O
Breitbart
A
A
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006312:Hearing Loss, Bilateral / Q000188:drug therapy*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D006801:Humans; D007238:Infarction / Q000188:drug therapy; D009553:Nimodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015356:Retinal Artery Occlusion / Q000188:drug therapy*; D013577:Syndrome; D014786:Vision Disorders / Q000188:drug therapy
D002121:Calcium Channel Blockers; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D009553:Nimodipine; D001241:Aspirin